Clinical Trials Browser

Phase EARLY_PHASE1 × INDUSTRY × Leukemia, Plasma Cell × Clear all

NCT06045091 2023-09-21

To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for Subjects With R/R MM or PCL

Phase EARLY_PHASE1 Recruiting

Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Multiple Myeloma